Integrated BioPharma, Inc.
INBP · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $808 | $112 | -$34 | $3,838 |
| Dep. & Amort. | $951 | $1,221 | $1,154 | $834 |
| Deferred Tax | $0 | $125 | $72 | -$1,530 |
| Stock-Based Comp. | $185 | $252 | $320 | $369 |
| Change in WC | -$1,502 | -$744 | -$302 | $565 |
| Other Non-Cash | $1,623 | -$23 | $22 | $15 |
| Operating Cash Flow | $2,065 | $943 | $1,232 | $4,091 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$191 | -$553 | -$116 | -$486 |
| Net Acquisitions | $0 | $0 | $4 | $21 |
| Inv. Purchases | $0 | $0 | -$4 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $4 | $0 |
| Other Inv. Act. | -$14 | $0 | $1 | $21 |
| Investing Cash Flow | -$205 | -$553 | -$111 | -$465 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$8 | -$42 | -$136 | -$3,539 |
| Stock Issued | $86 | $13 | $4 | $34 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $13 | $0 | $34 |
| Financing Cash Flow | $78 | -$29 | -$136 | -$3,505 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,938 | $361 | $985 | $121 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,677 | $1,316 | $331 | $210 |
| End Cash | $3,615 | $1,677 | $1,316 | $331 |
| Free Cash Flow | $1,874 | $390 | $1,116 | $3,605 |